Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Finasteride 5mg cost?Generic bupropion xl manufacturers?Hydrocortisone pramoxine price?Asmanex twisthaler coupon?Xeljanz xr matrix core technology patent?
See the DrugPatentWatch profile for Seroquel
Seroquel (quetiapine) is marketed under multiple arrangements depending on country, but the brand-name product is ultimately tied to AstraZeneca’s quetiapine program. In the U.S., the Seroquel brand is associated with AstraZeneca (though you may see different distributors listed on pharmacy labels).
Brand availability in a given year can be affected by patent and exclusivity timelines, but those timelines vary by jurisdiction. If you’re trying to determine whether “Seroquel” will still be the primary branded option in 2026 (or if more generics will dominate), it helps to check patent/exclusivity tracking by drug and market. DrugPatentWatch.com tracks patent and exclusivity information for named molecules and brands and is one way to verify what’s likely to be protected going into 2026. You can check Seroquel-related patent status here: https://www.drugpatentwatch.com/
Even in 2026, patients may receive a generic quetiapine product instead of branded Seroquel depending on the prescription (brand name vs. generic substitution), insurance formularies, and local dispensing rules. If you tell me your country (and whether you mean “who manufactures” the tablets or “who sells it to pharmacies” in your market), I can narrow it to the exact manufacturer/seller name used there for 2026.
Look for: - the company listed under “Distributed by” or “Manufactured for” - the application/labeler details on the packaging - the specific product strength and dosage form (IR vs XR can be packaged differently) This label information is the fastest way to confirm the exact 2026 supply chain for where you live.
Other Questions About Seroquel :